INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 178 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -88.9% | 64 | -88.8% | 0.00% | -100.0% |
| Q4 2021 | $9,000 | 0.0% | 571 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $9,000 | – | 579 | +6333.3% | 0.00% | – |
| Q1 2021 | $0 | – | 9 | -40.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 15 | -94.6% | 0.00% | -100.0% |
| Q2 2019 | $22,000 | +450.0% | 279 | +534.1% | 0.00% | +50.0% |
| Q1 2017 | $4,000 | -81.0% | 44 | -77.6% | 0.00% | -81.8% |
| Q4 2016 | $21,000 | -44.7% | 196 | -18.3% | 0.01% | -56.0% |
| Q3 2016 | $38,000 | +660.0% | 240 | +471.4% | 0.02% | +733.3% |
| Q2 2016 | $5,000 | -37.5% | 42 | -30.0% | 0.00% | -50.0% |
| Q4 2015 | $8,000 | – | 60 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Carmignac Gestion | 2,028,192 | $229,389,000 | 1.76% |
| Orbimed Advisors | 1,037,000 | $117,285,000 | 1.33% |
| BB BIOTECH AG | 255,719 | $28,922,000 | 0.95% |
| ALTRINSIC GLOBAL ADVISORS LLC | 193,369 | $21,870,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 44,573 | $5,041,000 | 0.67% |
| Rhenman & Partners Asset Management AB | 30,000 | $3,393,000 | 0.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 11,155 | $1,262,000 | 0.48% |
| NATIONAL PLANNING CORP | 52,400 | $5,888,000 | 0.44% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 364,232 | $41,195,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 15,000 | $1,697,000 | 0.33% |